TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Leo Pharma AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
43,944
|
51,798
|
55,441 |
Financial expenses |
39
|
138
|
85 |
Earnings before taxes |
2,380
|
2,126
|
701 |
Total assets |
38,999
|
34,933
|
30,224 |
Current assets |
38,996
|
34,929
|
30,217 |
Current liabilities |
21,436
|
18,111
|
15,511 |
Equity capital |
17,563
|
16,822
|
14,714 |
- share capital |
2,961
|
3,172
|
3,076 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
45.0%
|
48.2%
|
48.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
5.4%
|
4.1%
|
1.3% |
Return on assets (ROA) |
6.2%
|
6.5%
|
2.6% |
Current ratio |
181.9%
|
192.9%
|
194.8% |
Return on equity (ROE) |
13.6%
|
12.6%
|
4.8% |
Change turnover |
-4,421
|
-5,361
|
-20,790 |
Change turnover % |
-9%
![]() |
-9%
|
-27% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.